Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Shares withheld for taxes Chief Executive Officer gave up 3,505 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Legal Officer gave up 2,155 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Commercial Officer gave up 590 shares (to pay taxes)
  4. 4 Open-market sale Principal Accounting Officer sold 504 shares at $31.25 ($15,750)
  5. 4 Shares withheld for taxes Chief Medical Officer gave up 758 shares (to pay taxes)
  6. 4 Shares withheld for taxes Principal Accounting Officer gave up 273 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 1,349 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,073 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Legal Officer gave up 643 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Commercial Officer gave up 725 shares (to pay taxes)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,205 shares (to pay taxes)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Shares withheld for taxes Chief Medical Officer gave up 248 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 1,823 shares (to pay taxes)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Principal Accounting Officer sold 1,777 shares at $61.61 ($109,481)
  19. 4 Open-market sale Chief Medical Officer sold 48,493 shares at $60.11 ($2,914,851)
  20. 4 Open-market sale Chief Medical Officer sold 2,502 shares at $60.02 ($150,170)

Page 13 of 38 · 758 filings